Effect of naloxone on immune responses after hemorrhagic shock

Critical Care Medicine

Volumn 28, Issue 1, 2000, Pages 184-189

  Wichmann, Matthias W ^a,b   Zellweger, René ^a,c   Ayala, Alfred ^a   Chaudry, Irshad H ^a  

^a BROWN UNIVERSITY   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Corticosteronei interleukins; Hemorrhagic shock; Immune function; Lymphocyte; Macrophage; Mice; Naloxone; Opioid; Splenocyte

Indexed keywords

ENDORPHIN; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG EFFECT; HEMORRHAGIC SHOCK; IMMUNE RESPONSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RESUSCITATION;

EID: 0033953331     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200001000-00030     Document Type: Article

References (36)

1. 1. Chaudry IH, Ayala A, Ertel W, et al: Hemorrhage and resuscitation: Immunological aspects. Editorial Review. Am J Physiol 1990; 259:R663-R678
2. 2. Stephan RN, Kupper TS, Geha AS, et al: Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 1987; 122:62-68
3. 3. O'Benar JD, Hannon JP, Peterson JL, et al: Beta-endorphin, ACTH, and cortisol response to hemorrhage in conscious pigs. Am J Physiol 1987; 252:R953-R958
4. 4. Molina PE, Malek S, Lang CH, et al: Early organ specific hemorrhage-induced increases in tissue cytokine content: Associated neurohormonal and opioid alterations. Neuroimmunomodulation 1997; 4:28-36
5. 5. Gilman SC, Schwartz JM, Milner RJ, et al: β-Endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci U S A 1982; 79:4226-4230
6. 6. Shavit Y, Depaulis A, Martin FC, et al: Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc Natl Acad Sci U S A 1986; 83: 7114-7117
7. 7. Bessler H, Sztein MB, Serrate SA: β-Endorphin modulation of IL-1-induced IL-2 production. Immunopharmacology 1990; 19: 5-14
8. 8. Chamberlain JM, Klein BL: A comprehensive review of naloxone for the emergency physician. Am J Emerg Med 1994; 12:650-660
9. 9. Schmand JF, Ayala A, Morrison MH, et al: Dextran 70 administration after traumahemorrhagic shock does not impair cellular immune functions. J Crit Care 1994; 9:244-254
10. 10. Ayala A, Perrin MM, Wagner MA, et al: Enhanced susceptibility to sepsis following simple hemorrhage: Depression of Fc and C3b receptor mediated phagocytosis. Arch Surg 1990; 125:70-75
11. 11. Ihle JN, Keller J, Greenberger JS, et al: Phenotypic characteristics of cell lines requiring IL-3 for growth. J Immunol 1982; 129: 1377-1383
12. 12. Meldrum DR, Ayala A, Perrin MM, et al: Diltiazem restores IL-2, IL-3, IL-6 and IFN-gamma synthesis and decreases susceptibility to sepsis following hemorrhage. J Surg Res 1991; 51:158-164
13. 13. Mizel SB: Production and quantitation of lymphocyte-activating factor (interleukin 1). In: Manual of Macrophage Methodology. Herscowitz HB, Holden HT, Bellanti JA, et al (Eds). New York, Marcel Dekker, 1981, pp 407-441
14. 14. Ertel W, Morrison MH, Ayala A, et al: Chloroquine attenuates hemorrhagic shock induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. Blood 1991; 78:1781-1788
15. 15. Hültner L, Szöts H, Welle M, et al: Mouse bone marrow-derived interleukin 3-dependent mast cells and autonomous sublines produce interleukin 6. Immunology 1989; 67:408-413
16. 16. Ayala A, Perrin MP, Meldrum DR, et al: Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 1990; 2:170-174
17. 17. Ertel W, Morrison MH, Ayala A, et al: Interferon-γ attenuates hemorrhage-induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis. Surgery 1992; 111:177-187
18. 18. Grossman CJ: Stress and the immune response: Interactions of peptide, gonadal steroids and the immune system. In: Frontiers of Stress Research. Weiner H, Hellhammer D, Murison R, Florin I (Eds). Belin, Germany, Hans Huber, 1989, pp 209-234
19. 19. Bernton EW, Meltzer MS, Holaday JW: Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 1988; 239:401-404
20. 20. Harkema JM, Singh G, Wang P, et al: Pharmacologic agents in the treatment of ischemia, hemorrhagic shock, and sepsis. J Crit Care 1992; 7:189-216
21. 21. Holaday JW, Faden AI: Naloxone reversal of endotoxin hypotension suggests a role of endorphins in shock. Nature 1978; 275: 450-451
22. 22. Hinshaw LB, Archer LT, Beller BK, et al: Evaluation of naloxone therapy for Escherichia coli sepsis in the baboon. Arch Surg 1988; 123:700-704
23. 23. Caroleo MC, Arbitrio M, Melchiorri D, et al: A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity. Neuroimmunomodulation 1994; 1:141-147
24. 24. Chukwuocha RU, Reyes E, Tokuda S: The in vivo effects of opioid peptides on the murine immune response. Int J Jmmunopharmacol 1994; 16:205-215
25. 25. Freier DO, Fuchs BA: A mechanism of action for morphine-induced immunosuppression: Corticosterone mediates morphine-induced suppression of natural killer cell activity. J Pharmacol Exp Ther 1994; 270:1127-1133
26. 26. Lin J, Lu G, Weng J: Effects of beta-endorphin on phytohemagglutinin-induced lymphocyte proliferation and mouse plaque-forming cell response via an opioid receptor mechanism. Chin Med Sci J 1994; 9:245-247
27. 27. Bouix O, el Mezouini M, Orsetti A: Effects of naloxone opiate blockade on the immunomodulation induced by exercise in rats. Int J Sports Med 1995; 16:29-33
28. 28. Marotti T, Gabrilovac J, Rabatic S, et al: Metenkephalin modulates stress-induced alterations of the immune response in mice. Pharmacol Biochem Behav 1996; 54: 277-284
29. 29. Chaudry IH, Ayala A: Immunological Aspects of Hemorrhage. Austin, TX, Medical Intelligence Unit, RG Landes, 1992
30. 30. Chaudry IH, Ayala A, Meldrum D, et al: Hemorrhage-induced alterations in cell-mediated immune function. In: Host Defense Dysfunction in Trauma, Shock and Sepsis. Faist E, Meakins JL, Schildberg FW (Eds). Berlin, Springer-Verlag, 1993, pp 149-159
31. 31. Damas P, Ledoux D, Nys M, et al: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215:356-362
32. 32. O'Neill PJ, Ayala A, Wang P, et al: Role of Kupffer cells in interleukin-6 release following trauma-hemorrhage and resuscitation. Shock 1994; 1:43-47
33. 33. Claman HN: Corticosteroid and lymphoid cells. N Engl J Med 1972; 287:388-397
34. 34. Lee SW, Tsou AP, Chan H, et al: Glucocorticoids selectively inhibit the transcription of the interleukin 1β mRNA. Proc Natl Acad Sci U S A 1988; 85:1204-1208
35. + cells to release opioid agonist(s) with immunoenhancing and anti-stress properties. J Neuroimmunol 1990; 28: 167-176
36. 36. Barcellini W, Sacerdote P, Borghi MO, et al: β-Endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects. Peptides 1994; 15: 769-775